<SEC-DOCUMENT>0001193125-26-132644-index.html : 20260330
<SEC-HEADER>0001193125-26-132644.hdr.sgml : 20260330
<ACCEPTANCE-DATETIME>20260330192250
ACCESSION NUMBER:		0001193125-26-132644
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260326
FILED AS OF DATE:		20260330
DATE AS OF CHANGE:		20260330

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Daniel Mark James
		CENTRAL INDEX KEY:			0002092593
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35610
		FILM NUMBER:		26816004

	MAIL ADDRESS:	
		STREET 1:		1448 NW MARKET STREET
		STREET 2:		SUITE 500
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98107

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ATOSSA THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001488039
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				264753208
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1448 NW MARKET STREET
		STREET 2:		SUITE 500
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98107
		BUSINESS PHONE:		206.588.0256

	MAIL ADDRESS:	
		STREET 1:		1448 NW MARKET STREET
		STREET 2:		SUITE 500
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ATOSSA GENETICS INC
		DATE OF NAME CHANGE:	20100325
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>